O. Troum

Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study

Maxime Dougados, K. Kissel, Philip G. Conaghan et al. · Annals of the Rheumatic Diseases · 2014 · 152 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study

T. Huizinga, Philip G. Conaghan, E. Martín‐Mola et al. · Annals of the Rheumatic Diseases · 2014 · 111 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study

D E Furst, Norman Gaylis, Vance J. Bray et al. · Annals of the Rheumatic Diseases · 2007 · 103 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Rheumatoid Arthritis Disease Activity and Disability Affect the Risk of Serious Infection Events in RADIUS 1

Arthur L. Weaver, O. Troum, Michele Hooper et al. · The Journal of Rheumatology · 2013 · 54 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

The effects of tocilizumab on osteitis, synovitis and erosion progression in rheumatoid arthritis: results from the ACT-RAY MRI substudy

Philip G. Conaghan, Charles Peterfy, Ewa Olech et al. · Annals of the Rheumatic Diseases · 2014 · 47 citations · Full text

Medicine, Pharmacotherapy, Radiology +16